{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:53:13Z","timestamp":1783180393932,"version":"3.54.6"},"reference-count":42,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260908"],"award-info":[{"award-number":["82260908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Aspartame, a widely used artificial sweetener, has been linked to various cancers, including kidney renal papillary cell carcinoma (KIRP). However, the molecular mechanisms underlying this association remain unclear. This study employed network toxicology and molecular docking to investigate potential mechanisms of aspartame-induced KIRP. Differentially expressed genes from TCGA were intersected with aspartame targets and KIRP-related genes, yielding 61 common targets. GO and KEGG analyses revealed enrichment in extracellular matrix degradation, signaling pathways, and immune microenvironment regulation. Univariate Cox regression identified 23 prognostically significant genes, from which multifactorial Cox regression with stepwise selection determined 8 core genes (APLNR, CYP2C19, EDNRA, KLK5, F2R, RAD51, AURKA, and TLR2). A risk model was constructed and validated through VIF analysis, Schoenfeld residual testing, and internal validation using a training\u2013validation split. SHAP analysis identified EDNRA as the primary driver gene. Survival analysis demonstrated that the model effectively stratified KIRP patients, with risk score and tumor stage serving as independent prognostic factors. Molecular docking confirmed stable binding between aspartame and core target proteins. These findings provide mechanistic insights into aspartame-induced KIRP pathogenesis and establish a foundation for future experimental validation.<\/jats:p>","DOI":"10.3390\/ijms27010077","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:27:51Z","timestamp":1766586471000},"page":"77","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular Mechanisms of Aspartame-Induced Kidney Renal Papillary Cell Carcinoma Revealed by Network Toxicology and Molecular Docking Techniques"],"prefix":"10.3390","volume":"27","author":[{"given":"Chenjie","family":"Huang","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wei","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohong","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gedi","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Yan","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pat, Y., Yazici, D., Zeyneloglu, C., Babayev, H., Ardicli, S., Garci-Sanchez, A., Bu, X., Heider, A., Viscardi, O.G., and Chang, L. (2025). Cellular Stress, Inflammation and Barrier Damage in Gut Epithelial Cells Caused by Aspartame. Allergy, 1\u201318.","DOI":"10.1111\/all.70095"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kossiva, L., Kakleas, K., Christodouli, F., Soldatou, A., Karanasios, S., and Karavanaki, K. (2024). Chronic Use of Artificial Sweeteners: Pros and Cons. Nutrients, 16.","DOI":"10.3390\/nu16183162"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Doueihy, N.E., Ghaleb, J., Kfoury, K., Khouzami, K.K., Nassif, N., Attieh, P., Ghadieh, H.E., Azar, S., Kanaan, A., and Harb, F. (2025). Aspartame and Human Health: A Mini-Review of Carcinogenic and Systemic Effects. J. Xenobiotics, 15.","DOI":"10.3390\/jox15040114"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(23)00341-8","article-title":"Carcinogenicity of aspartame, methyleugenol, and isoeugenol","volume":"24","author":"Riboli","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_5","unstructured":"(2025, July 29). IARC Monographs on the Identification of Carcinogenic Hazards to Humans. Aspartame, Methyleugenol, and Isoeugenol. International Agency for Research on Cancer \u00a9 International Agency for Research on Cancer, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK609292\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100552","DOI":"10.1016\/j.advnut.2025.100552","article-title":"Lack of Genotoxic and Carcinogenic Potential for Nonsugar Sweeteners: A Review of Animal and Mechanistic Evidence","volume":"16","author":"Marchitti","year":"2025","journal-title":"Adv. Nutr."},{"key":"ref_7","first-page":"2022","article-title":"Renal cell carcinoma: An overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"Bahadoram","year":"2022","journal-title":"G. Ital. Nefrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"33509","DOI":"10.1038\/s41598-025-17389-0","article-title":"Identification of biomarkers for renal cell carcinoma in plasma samples measured using liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry","volume":"15","author":"Zhai","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00345-025-05880-2","article-title":"TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy","volume":"43","author":"Kessler","year":"2025","journal-title":"World J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.6004\/jnccn.2024.0008","article-title":"NCCN Guidelines\u00ae Insights: Kidney Cancer, Version 2.2024","volume":"22","author":"Motzer","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tung, I., and Sahu, A. (2021). Immune Checkpoint Inhibitor in First-Line Treatment of Metastatic Renal Cell Carcinoma: A Review of Current Evidence and Future Directions. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.707214"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"Chow","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12940-021-00725-y","article-title":"Aspartame and cancer\u2014New evidence for causation","volume":"20","author":"Landrigan","year":"2021","journal-title":"Environ. Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"118834","DOI":"10.1016\/j.ecoenv.2025.118834","article-title":"Revealing 1,3-diphenylpropane\u2019s coagulation toxicity via infomaxnet-based network toxicology and molecular simulations","volume":"303","author":"Pan","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev-biochem-030222-120000","article-title":"The Art and Science of Molecular Docking","volume":"93","author":"Paggi","year":"2024","journal-title":"Annu. Rev. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14737140.2024.2383675","article-title":"Understanding the link between aspartame and cancer","volume":"24","author":"Soffritti","year":"2024","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12967-024-06047-0","article-title":"An integrative analysis reveals cancer risk associated with artificial sweeteners","volume":"23","author":"Xie","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12161-024-02634-5","article-title":"An Investigation of the Toxicity and Mechanisms of Food Additives Based on Network Toxicology and GEO Databases: A Case Study of Aspartame","volume":"17","author":"Li","year":"2024","journal-title":"Food Anal. Methods"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"154664","DOI":"10.1016\/j.prp.2023.154664","article-title":"Oxidative stress affects the beginning of the growth of cancer cells through a variety of routes","volume":"249","author":"Saleh","year":"2023","journal-title":"Pathol.-Res. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"146564","DOI":"10.1016\/j.gene.2022.146564","article-title":"The Apelin\/APLNR system modulates tumor immune response by reshaping the tumor microenvironment","volume":"834","author":"Yang","year":"2022","journal-title":"Gene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41416-019-0396-7","article-title":"Apelin and apelin receptor expression in renal cell carcinoma","volume":"120","author":"Tolkach","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2014.05.011","article-title":"Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders","volume":"144","author":"Shahabi","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.intimp.2010.12.023","article-title":"Superoxide dismutase and cytochrome P450 isoenzymes might be associated with higher risk of renal cell carcinoma in male patients","volume":"11","author":"Sverko","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"AlRasheed, H., Almomen, A., Aljohar, H.I., Arafah, M., Almotawa, R.Y., Alossaimi, M.A., and Alzoman, N.Z. (2022). Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. Pharmaceuticals, 15, Correction in Pharmaceuticals 2025, 18, 1.","DOI":"10.3390\/ph18010001"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41420-022-00985-8","article-title":"Vascular derived endothelin receptor A controls endothelin-induced retinal ganglion cell death","volume":"8","author":"Marola","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e70172","DOI":"10.1111\/jcmm.70172","article-title":"EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy","volume":"28","author":"Wang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_27","first-page":"1619","article-title":"miR-200c regulates the proliferation, apoptosis and invasion of gastric carcinoma cells through the downregulation of EDNRA expression","volume":"41","author":"Wei","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102488","DOI":"10.1016\/j.tranon.2025.102488","article-title":"KLK5 and KLK7 drive cervical carcinoma via KLK14-dependent RhoA and NF-\u03baB pathways","volume":"60","author":"Vieira","year":"2025","journal-title":"Transl. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100970","DOI":"10.1016\/j.tranon.2020.100970","article-title":"Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma","volume":"14","author":"Alves","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"17876","DOI":"10.18632\/oncotarget.24947","article-title":"Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types","volume":"9","author":"Tailor","year":"2018","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Khetan, R., Lokman, N.A., Eldi, P., Price, Z.K., Oehler, M.K., Brooks, D.A., Blencowe, A., Garg, S., Ricciardelli, C., and Albrecht, H. (2025). Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic\/Prognostic and Treatment Applications for Patients with Ovarian Cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178529"},{"key":"ref_32","first-page":"177","article-title":"PAR-1- and PAR-3-type thrombin receptor expression in primary cultures of human renal cell carcinoma cells","volume":"20","author":"Kaufmann","year":"2002","journal-title":"Int. J. Oncol."},{"key":"ref_33","first-page":"889","article-title":"PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration","volume":"15","author":"Bergmann","year":"2006","journal-title":"Oncol. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Liu, H., Xia, Y., Chen, Y., Qi, H., Ji, H., Ji, S., and Lou, Y. (2025). RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant chemotherapy. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1548889"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00349","DOI":"10.1042\/BSR20160122","article-title":"Increased expression of SET domain-containing proteins and decreased expression of Rad51 in different classes of renal cell carcinoma","volume":"36","author":"Liu","year":"2016","journal-title":"Biosci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cpt.3584","article-title":"The Role and Mechanisms of Aurora Kinases in Kidney Diseases","volume":"117","author":"Chang","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/med.21399","article-title":"Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy","volume":"36","author":"Yan","year":"2016","journal-title":"Med. Res. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e27959","DOI":"10.1016\/j.heliyon.2024.e27959","article-title":"AURKA promotes renal cell carcinoma progression via regulation of CCNB1 transcription","volume":"10","author":"Wen","year":"2024","journal-title":"Heliyon"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kos, M., Bojarski, K., Mertowska, P., Mertowski, S., Tomaka, P., Dziki, \u0141., and Grywalska, E. (2024). New Horizons in the Diagnosis of Gastric Cancer: The Importance of Selected Toll-like Receptors in Immunopathogenesis Depending on the Stage, Clinical Subtype, and Gender of Newly Diagnosed Patients. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179264"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4436646","DOI":"10.1155\/2022\/4436646","article-title":"Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer","volume":"2022","author":"Ping","year":"2022","journal-title":"BioMed Res. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2325765","DOI":"10.1155\/2019\/2325765","article-title":"Cell Adhesion-Related Molecules Play a Key Role in Renal Cancer Progression by Multinetwork Analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","article-title":"A Caution Regarding Rules of Thumb for Variance Inflation Factors","volume":"41","year":"2007","journal-title":"Qual. Quant."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/77\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T14:30:02Z","timestamp":1766586602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27010077"],"URL":"https:\/\/doi.org\/10.3390\/ijms27010077","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}